Shared Mechanisms Govern HIV Transcriptional Suppression in Circulating CD103 + and Gut CD4 + T Cells
- 22 December 2020
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 95 (2)
Abstract
The ability of HIV to establish a reversibly silent, “latent” infection is widely regarded as the main barrier to curing HIV. Most HIV-infected cells reside in tissues such as the gut, but it is unclear what mechanisms maintain HIV latency in the blood or gut. We found that circulating CD103 + CD4 + T cells are enriched for HIV-infected cells in a latent-like state. Using RNA sequencing (RNA-seq), we found that CD103 + T cells share a cellular transcriptome that more closely resembles that of CD4 + T cells from the gut, suggesting that they are homing to or from the gut. We also identified the cellular genes whose expression distinguishes gut CD4 + or circulating CD103 + T cells from circulating CD103 − T cells, including some genes that have been implicated in HIV expression. These genes may contribute to latent HIV infection in the gut and may serve as new targets for therapies aimed at curing HIV.Keywords
Funding Information
- HHS | National Institutes of Health (R01 AI127219)
- HHS | National Institutes of Health (P01 AI131374)
- HHS | National Institutes of Health (DP2 AI112244)
- HHS | National Institutes of Health (P30 AI027763)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI132128)
- amfAR, The Foundation for AIDS Research (109301)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK108349)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK120387)
- California HIV/AIDS Research Program (CHRP ID15-GI-059)
This publication has 80 references indexed in Scilit:
- Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV CureAIDS Research and Human Retroviruses, 2017
- Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication StudiesPLOS Pathogens, 2013
- HIV Persistence in the Gut Mucosa of HIV-Infected Subjects Undergoing Antiretroviral Therapy Correlates with Immune Activation and Increased Levels of LPSCurrent HIV Research, 2011
- Differences in HIV Burden and Immune Activation within the Gut of HIV‐Positive Patients Receiving Suppressive Antiretroviral TherapyThe Journal of Infectious Diseases, 2010
- Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral TherapyThe Journal of Infectious Diseases, 2008
- The intestinal mucosa as a reservoir of HIV-1 infection after successful HAARTAIDS, 2007
- Lack of Decay of HIV-1 in Gut-Associated Lymphoid Tissue Reservoirs in Maximally Suppressed IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma ViremiaScience, 1997
- Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral TherapyScience, 1997
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997